U.K. Blood Testing Market Size & Outlook, 2025-2030
- Clinical Diagnostics
- In Vitro Diagnostics
- Blood Testing Market Outlook
- In Vitro Diagnostics
Global Market
Related Markets
Ask a question about the blood testing market
UK blood testing market highlights
- The UK blood testing market generated a revenue of USD 1,653.6 million in 2024 and is expected to reach USD 2,644.9 million by 2030.
- The UK market is expected to grow at a CAGR of 8.3% from 2025 to 2030.
- In terms of segment, glucose testing was the largest revenue generating test type in 2024.
- Glucose testing is the most lucrative test type segment registering the fastest growth during the forecast period.
Blood testing market data book summary
| Market revenue in 2024 | USD 1,653.6 million |
| Market revenue in 2030 | USD 2,644.9 million |
| Growth rate | 8.3% (CAGR from 2025 to 2030) |
| Largest segment | Glucose testing |
| Fastest growing segment | Glucose testing |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Glucose testing, A1C testing, Direct LDL testing, Lipid panel testing, Prostate-specific antigen testing, COVID-19 testing, BUN testing, Vitamin D testing, Thyroid-stimulating hormone testing, Serum Nicotine / Cotinine testing, High sensitivity CRP testing, Testosterone testing, ALT testing, Cortisol testing, Creatinine testing, AST testing, Other blood tests |
| Key market players worldwide | Abbott Laboratories, Roche Holding AG ADR, Bio-Rad Laboratories Inc, BioMerieux SA, Quest Diagnostics Inc, Biomerica Inc, Becton Dickinson & Co, Siemens Healthineers AG ADR, Danaher Corp, Trinity Biotech PLC ADR |
Other key industry trends
- In terms of revenue, UK accounted for 1.7% of the global blood testing market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany blood testing market is projected to lead the regional market in terms of revenue in 2030.
- Russia is the fastest growing regional market in Europe and is projected to reach USD 2,254.6 million by 2030.
The UK is expected to exhibit the CAGR of 4.7% over the forecast period owing to new donations, rising prevalence of chronic diseases, and well-established healthcare infrastructure. Data from the Public Health England suggests that an estimated 14,071 individuals, or 6.4% of the population, in the UK were suffering from diabetes in 2017-2018.
Patients suffering from diabetes are at a higher risk of developing cardiovascular complications such as angina, stroke, and heart attack & failure and microvascular complications (amputation and renal disease). Thus, rising incidence of diabetes in the nation is estimated to drive the market growth.
According to NHS, an estimated 85,000 individuals are admitted due to stroke each year. Data from the same source also suggests that over 1 million individuals have survived a stroke in the nation with half of this population suffering from some form of disability causing severe complications.
No credit card required*
Publish Date: Nov 07, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Blood Testing Market Scope
Blood Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Becton Dickinson & Co | View profile | 73,000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | www.bd.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Quest Diagnostics Inc | View profile | 48,000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | www.questdiagnostics.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Biomerica Inc | View profile | 62 | 17571 Von Karman Avenue, Irvine, CA, United States, 92614 | www.biomerica.com |
| Trinity Biotech PLC ADR | View profile | 380 | IDA Business Park, Bray, County Wicklow, Dublin, Ireland, A98 H5C8 | www.trinitybiotech.com |
U.K. Blood Testing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Blood Testing Market Outlook will help companies and investors design strategic landscapes.
Glucose Testing was the largest segment with a revenue share of 19.68% in 2024.
Horizon Databook has segmented the U.K. blood testing market based on glucose testing, a1c testing, direct ldl testing, lipid panel testing, prostate-specific antigen testing, covid-19 testing, bun testing, vitamin d testing, thyroid-stimulating hormone testing, serum nicotine / cotinine testing, high sensitivity crp testing, testosterone testing, alt testing, cortisol testing, creatinine testing, ast testing, other blood tests covering the revenue growth of each sub-segment from 2018 to 2030.
The UK is expected to exhibit the CAGR of 4.7% over the forecast period owing to new donations, rising prevalence of chronic diseases, and well-established healthcare infrastructure. Data from the Public Health England suggests that an estimated 14,071 individuals, or 6.4% of the population, in the UK were suffering from diabetes in 2017-2018.
Patients suffering from diabetes are at a higher risk of developing cardiovascular complications such as angina, stroke, and heart attack & failure and microvascular complications (amputation and renal disease). Thus, rising incidence of diabetes in the nation is estimated to drive the market growth.
According to NHS, an estimated 85,000 individuals are admitted due to stroke each year. Data from the same source also suggests that over 1 million individuals have survived a stroke in the nation with half of this population suffering from some form of disability causing severe complications.
- U.K. Blood Testing Market Test Type Outlook (Revenue, USD Million , 2018-2030)
- Glucose testing
- A1C testing
- Direct LDL testing
- Lipid panel testing
- Prostate-specific antigen testing
- COVID-19 testing
- BUN testing
- Vitamin D testing
- Thyroid-stimulating hormone testing
- Serum Nicotine / Cotinine testing
- High sensitivity CRP testing
- Testosterone testing
- ALT testing
- Cortisol testing
- Creatinine testing
- AST testing
- Other blood tests
Reasons to subscribe to Blood Testing Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Blood Testing Market Outlook databook
- Our clientele includes a mix of Blood Testing Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.K. Blood Testing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.K. Blood Testing Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
U.K. Blood Testing Market, 2018-2030 (US$M)
UK blood testing market statistics, by test type, 2018-2030 (US$M)
